about us main logo


NanoViricides Inc.

1 Controls Drive,
Shelton, CT 06484
Ph No:- 203-937-6137
Fax No:- 203-859-5095
Email:- info@nanoviricides.com
















Welcome to NanoViricide's Investor Relations section.

NanoViricides, Inc. is a leading company in the application of nanomedicine technologies to the complex issues of viral diseases. The nanoviricide® technology permits direct attacks at multiple points on a virus particle. It is believed that such actions lead to the virus particle becoming ineffective at infecting cells. Antibodies in contrast attack a virus particle at only a maximum of two attachment points per antibody.

We have been aggressively expanding our portfolio of virus targets and drug candidates every year since our inception in May, 2005.

Most Recent Fact Sheet

Nanoviricides Inc Fact Sheet: September 9th, 2019

Most Recent Presentation

Eradicating Diseases Caused by Viruses Using 21st Century Nanotechnology
Presented by: Eugene Seymour, MD, MPH
Chief Executive Officer
December - 2017

Most Recent Press Releases





04-15-2014 NanoViricides won the IAIR AWARD
NanoViricides won the IAIR AWARD as Best North American Company for Leadership in the Nanomedicine Sector.
02-20-2014Dr. Anil R. Diwan Recognized as            "Researcher of the year".
NanoViricides, Inc. President Dr. Anil R. Diwan Recognized as "Researcher of the Year" by BusinessNewHaven, a Connecticut Area Business Journal.














Contact Information

NanoViricides, Inc.
1 Controls Drive,
Shelton, CT 06484

Phone: +1-203-937-6137
Phone: +1-888-591-3579
Fax: +1-203-859-5095
E-mail: info@nanoviricides.com